Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilakshi Barua

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biomolecules|September 28, 2021
Therapeutic Potential of Curcumin as an Antimycobacterial AgentNilakshi Barua, Alak Kumar Buragohain
Antibiotics (Basel, Switzerland)|November 27, 2024
Therapeutic Potential of Silver Nanoparticles (AgNPs) as an Antimycobacterial Agent: A Comprehensive ReviewNilakshi Barua, Alak Kumar Buragohain
Frontiers in Immunology|October 31, 2022
Mucin-degrading gut commensals isolated from healthy faecal donor suppress intestinal epithelial inflammation and regulate tight junction barrier functionMingfang Pan, Nilakshi Barua, Margaret Ip
Biomedicines|January 21, 2022
<i>VraSR</i> Regulatory System Contributes to the Virulence of Community-Associated Methicillin-Resistant <i>Staphylococcus aureus</i> (CA-MRSA) in a 3D-Skin Model and Skin Infection of Humanized Mouse ModelNilakshi Barua, Ying Yang, Lin Huang, et al.
Biomaterials Science|June 3, 2020
Bio-based hyperbranched poly(ester amide)-MWCNT nanocomposites: multimodalities at the biointerfaceSujata Pramanik, Rocktotpal Konwarh, Nilakshi Barua, et al.
Chemical Biology & Drug Design|December 14, 2011
DFT-based QSAR models to predict the antimycobacterial activity of chalconesNilakshi Barua, Pubalee Sarmah, Iftikar Hussain, et al.
Gut Microbes|May 23, 2024
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomesMd Nannur Rahman, Nilakshi Barua, Martha C F Tin, et al.
Biomedicines|March 28, 2025
Antivirulence Properties of Kuraridin Against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)Nilakshi Barua, Ben Chung Lap Chan, Clara Bik-San Lau, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Enhancing Antibiotics Efficacy by Combination of Kuraridin and Epicatechin Gallate with Antimicrobials against Methicillin-Resistant <i>Staphylococcus aureus</i>Ben Chung-Lap Chan, Nilakshi Barua, Clara Bik-San Lau, et al.
Plos One|December 23, 2021
Chimeric crRNA improves CRISPR-Cas12a specificity in the N501Y mutation detection of Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2Jun Yang, Nilakshi Barua, Md Nannur Rahman, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biomolecules|September 28, 2021
Therapeutic Potential of Curcumin as an Antimycobacterial AgentNilakshi Barua, Alak Kumar Buragohain
Antibiotics (Basel, Switzerland)|November 27, 2024
Therapeutic Potential of Silver Nanoparticles (AgNPs) as an Antimycobacterial Agent: A Comprehensive ReviewNilakshi Barua, Alak Kumar Buragohain
Frontiers in Immunology|October 31, 2022
Mucin-degrading gut commensals isolated from healthy faecal donor suppress intestinal epithelial inflammation and regulate tight junction barrier functionMingfang Pan, Nilakshi Barua, Margaret Ip
Biomedicines|January 21, 2022
<i>VraSR</i> Regulatory System Contributes to the Virulence of Community-Associated Methicillin-Resistant <i>Staphylococcus aureus</i> (CA-MRSA) in a 3D-Skin Model and Skin Infection of Humanized Mouse ModelNilakshi Barua, Ying Yang, Lin Huang, et al.
Biomaterials Science|June 3, 2020
Bio-based hyperbranched poly(ester amide)-MWCNT nanocomposites: multimodalities at the biointerfaceSujata Pramanik, Rocktotpal Konwarh, Nilakshi Barua, et al.
Chemical Biology & Drug Design|December 14, 2011
DFT-based QSAR models to predict the antimycobacterial activity of chalconesNilakshi Barua, Pubalee Sarmah, Iftikar Hussain, et al.
Gut Microbes|May 23, 2024
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomesMd Nannur Rahman, Nilakshi Barua, Martha C F Tin, et al.
Biomedicines|March 28, 2025
Antivirulence Properties of Kuraridin Against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)Nilakshi Barua, Ben Chung Lap Chan, Clara Bik-San Lau, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Enhancing Antibiotics Efficacy by Combination of Kuraridin and Epicatechin Gallate with Antimicrobials against Methicillin-Resistant <i>Staphylococcus aureus</i>Ben Chung-Lap Chan, Nilakshi Barua, Clara Bik-San Lau, et al.
Plos One|December 23, 2021
Chimeric crRNA improves CRISPR-Cas12a specificity in the N501Y mutation detection of Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2Jun Yang, Nilakshi Barua, Md Nannur Rahman, et al.
Pageof 2